Typicality: | 0.291 |
Saliency: | 0.098 |
to provide ascvd risk-reductionbenefits | 6 | purpose |
preference → go to → drug | 6 |
negative | neutral | positive |
0.065 | 0.657 | 0.278 |
Raw frequency | 6 |
Normalized frequency | 0.098 |
Modifier score | 0.500 |
Perplexity | 165.339 |